ID   HMT-3909S1
AC   CVCL_6856
SY   HMT-3909-S1; HMT-3909 S1; HMT3909S1; HMT-3909 subline S1
DR   cancercelllines; CVCL_6856
DR   Wikidata; Q54889972
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=2153455;
RX   PubMed=7786603;
CC   Group: Serum/protein free medium cell line.
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Non-tumorigenic.
CC   Doubling time: 55 hours (PubMed=7786603).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg249Gly (c.745A>G); ClinVar=VCV000376654; Zygosity=Unspecified (PubMed=7786603).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6858 ! HMT-3909
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 14
//
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RA   Leibovitz A.;
RT   "Cell lines from human breast.";
RL   (In) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.161-184; Academic Press; New York (1994).
//
RX   PubMed=2153455;
RA   Petersen O.W., van Deurs B., Nielsen K.V., Madsen M.W., Laursen I.,
RA   Balslev I., Briand P.;
RT   "Differential tumorigenicity of two autologous human breast carcinoma
RT   cell lines, HMT-3909S1 and HMT-3909S8, established in serum-free
RT   medium.";
RL   Cancer Res. 50:1257-1270(1990).
//
RX   PubMed=7786603; DOI=10.1016/0959-8049(94)00480-S;
RA   Madsen M.W., Moyret C., Theillet C., Briand P.;
RT   "Growth factor requirement, oncogene expression and TP53 mutations of
RT   a tumorigenic and a non-tumorigenic subline of the human breast
RT   carcinoma cell line, HMT-3909.";
RL   Eur. J. Cancer 31:362-367(1995).
//